
Minimally invasive surgical enucleation for esophageal leiomyoma: report of seven cases
Author(s) -
Obuchi T.,
Sasaki A.,
Nitta H.,
Koeda K.,
Ikeda K.,
Wakabayashi G.
Publication year - 2010
Publication title -
diseases of the esophagus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 63
eISSN - 1442-2050
pISSN - 1120-8694
DOI - 10.1111/j.1442-2050.2008.00917.x
Subject(s) - enucleation , medicine , leiomyoma , surgery , esophagus , lesion , laparoscopy
SUMMARY Benign esophageal tumor is a rare entity, with leiomyoma being the most common lesion. We present our experience with enucleation of esophageal leiomyomas using a minimally invasive approach. Between March 1998 and June 2008, seven patients with esophageal leiomyoma underwent right thoracosopic enucleation ( n = 4) or laparoscopic transhiatal enucleation ( n = 3). A Dor ( n = 2) or Toupet fundoplication ( n = 1) were added for laparoscopic procedure. The mean tumor size was 3.9 cm (range, 1.5–5.5 cm). Tumor locations were upper ( n = 2), middle ( n = 1), and lower ( n = 4) thirds of the esophagus. No major morbidities including postoperative leakage or mortalities occurred. At a mean follow‐up period of 60.1 months (range, 14–260 months), no evidence of recurrences were observed. Thoracoscopic and laparoscopic transhiatal enucleation for esophageal leiomyomas is a safe and feasible procedure. The optimal approaches should be tailored based on the location and size of the tumor.